AbbVie's (ABBV) Botox Study Shows Promising Results for Essentia - GuruFocus
AbbVie's (ABBV) Botox Study Shows Promising Results for Essentia GuruFocus
GuruFocus
Oct 06, 2025
Allergan/AbbVie (11)
AbbVie's Botox Shows Improvement In Movement Disorder Study - inkl
AbbVie's Botox Shows Improvement In Movement Disorder Study inkl
inkl
Oct 06, 2025
AbbVie succeeds in mid-stage study of Botox for essential tremor - Seeking Alpha
AbbVie succeeds in mid-stage study of Botox for essential tremor Seeking Alpha
Seeking Alpha
Oct 06, 2025
AbbVie Says Phase 2 ELATE Trial Met Primary Endpoint For BOTOX To Treat Upper Limb Essential Tremor - Nasdaq
AbbVie Says Phase 2 ELATE Trial Met Primary Endpoint For BOTOX To Treat Upper Limb Essential Tremor Nasdaq
Nasdaq
Oct 06, 2025
AbbVie Announces Positive Topline Results from Phase 2 ELATE Trial Evaluating OnabotulinumtoxinA (BOTOX®) for the Treatment of Upper Limb Essential Tremor - Stock Titan
AbbVie Announces Positive Topline Results from Phase 2 ELATE Trial Evaluating OnabotulinumtoxinA (BOTOX®) for the Treatment of Upper Limb Essential Tremor Stock Titan
Stock Titan
Oct 06, 2025
Allergan Aesthetics’ New Report Aims to Debunk Common Hyaluronic Acid Filler Myths - NewBeauty
Allergan Aesthetics’ New Report Aims to Debunk Common Hyaluronic Acid Filler Myths NewBeauty
NewBeauty
Sep 25, 2025
BOTOX® Cosmetic (onabotulinumtoxinA) Unveils "The One & Only" Campaign Featuring Real People and Their Distinctive Stories - AbbVie News Center
BOTOX® Cosmetic (onabotulinumtoxinA) Unveils "The One & Only" Campaign Featuring Real People and Their Distinctive Stories AbbVie News Center
AbbVie News Center
Sep 09, 2025
Allergan Aesthetics Launches Campaign to Educate Consumers about Hyaluronic Acid (HA) Injectable Fillers - Yahoo Finance
Allergan Aesthetics Launches Campaign to Educate Consumers about Hyaluronic Acid (HA) Injectable Fillers Yahoo Finance
Yahoo Finance
Sep 03, 2025
Allergan's New Campaign and Data Report Fights Misinformation on Hyaluronic Acid Fillers - Dermatology Times
Allergan's New Campaign and Data Report Fights Misinformation on Hyaluronic Acid Fillers Dermatology Times
Dermatology Times
Sep 03, 2025
Allergan Aesthetics Launches Campaign to Educate Consumers about Hyaluronic Acid (HA) Injectable Fillers - AbbVie News Center
Allergan Aesthetics Launches Campaign to Educate Consumers about Hyaluronic Acid (HA) Injectable Fillers AbbVie News Center
AbbVie News Center
Sep 03, 2025
Illinois secures AbbVie’s $195 million investment for North Chicago facility - MyStateline
Illinois secures AbbVie’s $195 million investment for North Chicago facility MyStateline
MyStateline
Aug 12, 2025
Galderma (2)
Galderma to present post-marketing data from ARTIST study on its Restylane hyaluronic acid injectables portfolio - MarketScreener
Galderma to present post-marketing data from ARTIST study on its Restylane hyaluronic acid injectables portfolio MarketScreener
MarketScreener
Sep 24, 2025
Galderma Showcases Innovations for Skin Regeneration - Mexico Business News
Galderma Showcases Innovations for Skin Regeneration Mexico Business News
Mexico Business News
Sep 01, 2025
Evolus (4)
Top Miami Plastic Surgeon Dr. Benjamin Eskenazi Named Lead Consultant for Evolus' Evolysse™ Filler Launch - PR Newswire
Top Miami Plastic Surgeon Dr. Benjamin Eskenazi Named Lead Consultant for Evolus' Evolysse™ Filler Launch PR Newswire
PR Newswire
Sep 22, 2025
Evolus Is Seeking FDA Approval for Its Latest HA Filler - NewBeauty
Evolus Is Seeking FDA Approval for Its Latest HA Filler NewBeauty
NewBeauty
Aug 25, 2025
Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for Evolysse™ Sculpt Injectable Hyaluronic Acid Gel Product - Business Wire
Evolus Announces Submission of Premarket Approval Application to the U.S. Food and Drug Administration for Evolysse™ Sculpt Injectable Hyaluronic Acid Gel Product Business Wire
Business Wire
Aug 20, 2025
Evolus Submits Evolysse Sculpt for FDA Approval, Expanding HA Dermal Filler Portfolio - Dermatology Times
Evolus Submits Evolysse Sculpt for FDA Approval, Expanding HA Dermal Filler Portfolio Dermatology Times
Dermatology Times
Aug 20, 2025
New Entrants (0)
No recent news found
Market/Regulatory (1)
U.S. Botox Market Set for Dynamic Growth with Key Players Allergan, Galderma, Ipsen, and Revance - openPR.com
U.S. Botox Market Set for Dynamic Growth with Key Players Allergan, Galderma, Ipsen, and Revance openPR.com
openPR.com
Oct 06, 2025